Skip to main navigation
Media
Investors
Contact Us
Science
Medicines
Stories
Company
Careers
Our
Science
Pipeline
Explore our pipeline of investigational RAS(ON) inhibitors.
Tri-Complex Platform and RAS(ON) Biology
Explore RAS(ON) biology and the platform driving targeted therapy discovery and development.
Research, Grants & Support
Learn about funding, research collaboration, and community support at RevMed.
Publications
Access scientific publications, congress presentations, and RAS(ON) research.
Our
Stories
Revolution RAS
Enter Revolution RAS, where the mindset behind Revolution Medicines comes to life. See what drives us, how we challenge convention, and why we are taking on RAS-addicted cancers.
Stories
Perspectives about our science, our people, RAS-addicted cancers, and life at Revolution Medicines.
Our
Company
About RevMed
Learn about our mission, values, and the team advancing therapies for RAS-addicted cancers.
Responsibility
Learn about our approach to pricing and patient access, and corporate responsibility.
Science
Pipeline
Explore our pipeline of investigational RAS(ON) inhibitors.
Tri-Complex Platform and RAS(ON) Biology
Explore RAS(ON) biology and the platform driving targeted therapy discovery and development.
Research, Grants & Support
Learn about funding, research collaboration, and community support at RevMed.
Publications
Access scientific publications, congress presentations, and RAS(ON) research.
Medicines
Stories
Revolution RAS
Enter Revolution RAS, where the mindset behind Revolution Medicines comes to life. See what drives us, how we challenge convention, and why we are taking on RAS-addicted cancers.
Stories
Perspectives about our science, our people, RAS-addicted cancers, and life at Revolution Medicines.
Company
About RevMed
Learn about our mission, values, and the team advancing therapies for RAS-addicted cancers.
Responsibility
Learn about our approach to pricing and patient access, and corporate responsibility.
Careers
Media
Investors
Contact Us
Biography
Investor Relations
Overview
Events & Presentations
Governance
Governance Overview
Board of Directors
Management
Stock Information
Stock Quote & Chart
Analyst Coverage
SEC Filings
EQRx Acquisition Information
IRS Form 8937 for EQRx Shareholders
Resources
Investor FAQs
Email Alerts
Contact IR
Mark A. Goldsmith, M.D., Ph.D.
President, Chief Executive Officer and Director
Chairman of the Board
